156 related articles for article (PubMed ID: 21782616)
21. Transport of nickel across monolayers of human intestinal Caco-2 cells.
Tallkvist J; Tjälve H
Toxicol Appl Pharmacol; 1998 Jul; 151(1):117-22. PubMed ID: 9705894
[TBL] [Abstract][Full Text] [Related]
22. Transepithelial transport of putrescine across monolayers of the human intestinal epithelial cell line, Caco-2.
Milovic V; Turchanowa L; Stein J; Caspary WF
World J Gastroenterol; 2001 Apr; 7(2):193-7. PubMed ID: 11819759
[TBL] [Abstract][Full Text] [Related]
23. Epithelial cells in culture as a model for the intestinal transport of antimicrobial agents.
Ranaldi G; Islam K; Sambuy Y
Antimicrob Agents Chemother; 1992 Jul; 36(7):1374-81. PubMed ID: 1510430
[TBL] [Abstract][Full Text] [Related]
24. Role of P-glycoprotein-mediated secretion in absorptive drug permeability: An approach using passive membrane permeability and affinity to P-glycoprotein.
Döppenschmitt S; Spahn-Langguth H; Regårdh CG; Langguth P
J Pharm Sci; 1999 Oct; 88(10):1067-72. PubMed ID: 10514357
[TBL] [Abstract][Full Text] [Related]
25. Modulation of P-glycoprotein function in human lymphocytes and Caco-2 cell monolayers by HIV-1 protease inhibitors.
Profit L; Eagling VA; Back DJ
AIDS; 1999 Sep; 13(13):1623-7. PubMed ID: 10509562
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of P-glycoprotein-mediated vinblastine transport across HCT-8 intestinal carcinoma monolayers by verapamil, cyclosporine A and SDZ PSC 833 in dependence on extracellular pH.
Zacherl J; Hamilton G; Thalhammer T; Riegler M; Cosentini EP; Ellinger A; Bischof G; Schweitzer M; Teleky B; Koperna T
Cancer Chemother Pharmacol; 1994; 34(2):125-32. PubMed ID: 7910786
[TBL] [Abstract][Full Text] [Related]
27. Transepithelial transport properties of peptidomimetic thrombin inhibitors in monolayers of a human intestinal cell line (Caco-2) and their correlation to in vivo data.
Walter E; Kissel T; Reers M; Dickneite G; Hoffmann D; Stüber W
Pharm Res; 1995 Mar; 12(3):360-5. PubMed ID: 7617521
[TBL] [Abstract][Full Text] [Related]
28. Intestinal absorptive transport of the hydrophilic cation ranitidine: a kinetic modeling approach to elucidate the role of uptake and efflux transporters and paracellular vs. transcellular transport in Caco-2 cells.
Bourdet DL; Pollack GM; Thakker DR
Pharm Res; 2006 Jun; 23(6):1178-87. PubMed ID: 16741656
[TBL] [Abstract][Full Text] [Related]
29. H(+)-coupled dipeptide (glycylsarcosine) transport across apical and basal borders of human intestinal Caco-2 cell monolayers display distinctive characteristics.
Thwaites DT; Brown CD; Hirst BH; Simmons NL
Biochim Biophys Acta; 1993 Sep; 1151(2):237-45. PubMed ID: 8373798
[TBL] [Abstract][Full Text] [Related]
30. [Absorption and transport of isoflavonoid compounds from Tongmai formula across human intestinal epithelial (Caco-2) cells in vitro].
Wang FR; Yang XW
Zhongguo Zhong Yao Za Zhi; 2017 Aug; 42(16):3206-3212. PubMed ID: 29171242
[TBL] [Abstract][Full Text] [Related]
31. Transport of rhodamine 123, a P-glycoprotein substrate, across rat intestine and Caco-2 cell monolayers in the presence of cytochrome P-450 3A-related compounds.
Yumoto R; Murakami T; Nakamoto Y; Hasegawa R; Nagai J; Takano M
J Pharmacol Exp Ther; 1999 Apr; 289(1):149-55. PubMed ID: 10086998
[TBL] [Abstract][Full Text] [Related]
32. In vitro and in situ absorption of SDZ-RAD using a human intestinal cell line (Caco-2) and a single pass perfusion model in rats: comparison with rapamycin.
Crowe A; Lemaire M
Pharm Res; 1998 Nov; 15(11):1666-72. PubMed ID: 9833985
[TBL] [Abstract][Full Text] [Related]
33. Comparison of ceftibuten transport across Caco-2 cells and rat jejunum mounted on modified Ussing chambers.
Menon RM; Barr WH
Biopharm Drug Dispos; 2003 Oct; 24(7):299-308. PubMed ID: 14520683
[TBL] [Abstract][Full Text] [Related]
34. Comparison of HT29-18-C1 and Caco-2 cell lines as models for studying intestinal paracellular drug absorption.
Collett A; Sims E; Walker D; He YL; Ayrton J; Rowland M; Warhurst G
Pharm Res; 1996 Feb; 13(2):216-21. PubMed ID: 8932439
[TBL] [Abstract][Full Text] [Related]
35. Transcellular and lipophilic complex-enhanced intestinal absorption of human growth hormone.
Wu SJ; Robinson JR
Pharm Res; 1999 Aug; 16(8):1266-72. PubMed ID: 10468030
[TBL] [Abstract][Full Text] [Related]
36. Pluronic P85 increases permeability of a broad spectrum of drugs in polarized BBMEC and Caco-2 cell monolayers.
Batrakova EV; Li S; Miller DW; Kabanov AV
Pharm Res; 1999 Sep; 16(9):1366-72. PubMed ID: 10496651
[TBL] [Abstract][Full Text] [Related]
37. A tunable Caco-2/HT29-MTX co-culture model mimicking variable permeabilities of the human intestine obtained by an original seeding procedure.
Béduneau A; Tempesta C; Fimbel S; Pellequer Y; Jannin V; Demarne F; Lamprecht A
Eur J Pharm Biopharm; 2014 Jul; 87(2):290-8. PubMed ID: 24704198
[TBL] [Abstract][Full Text] [Related]
38. Caco-2 cells and Biopharmaceutics Classification System (BCS) for prediction of transepithelial transport of xenobiotics (model drug: caffeine).
Smetanova L; Stetinova V; Kholova D; Kvetina J; Smetana J; Svoboda Z
Neuro Endocrinol Lett; 2009; 30 Suppl 1():101-5. PubMed ID: 20027153
[TBL] [Abstract][Full Text] [Related]
39. Omeprazole decreases magnesium transport across Caco-2 monolayers.
Thongon N; Krishnamra N
World J Gastroenterol; 2011 Mar; 17(12):1574-83. PubMed ID: 21472124
[TBL] [Abstract][Full Text] [Related]
40. A biophysical model of passive and polarized active transport processes in Caco-2 cells: approaches to uncoupling apical and basolateral membrane events in the intact cell.
Ho NF; Burton PS; Conradi RA; Barsuhn CL
J Pharm Sci; 1995 Jan; 84(1):21-7. PubMed ID: 7714738
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
